TGFBR2 Antikörper (AA 25-159)

Produktnummer ABIN7171961

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch TGFBR2 in ELISA, IHC und IF. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für TGFBR2 Antikörper (AA 25-159) (ABIN7171961)

Target: TGFBR2 (Transforming Growth Factor, beta Receptor II (70/80kDa) (TGFBR2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TGFBR2 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Produktdetails anti-TGFBR2 Antikörper

Bindungsspezifität: AA 25-159

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human TGF-beta receptor type-2 protein (25-159AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu TGFBR2

Target: TGFBR2 (Transforming Growth Factor, beta Receptor II (70/80kDa) (TGFBR2))

Andere Bezeichnung: TGFBR2

Hintergrund:

Background: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 Molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.

Aliases: AAT3 antibody, FAA3 antibody, LDS1B antibody, LDS2 antibody, LDS2B antibody, MFS2 antibody, RIIC antibody, TAAD2 antibody, TbetaR II antibody, TbetaR-II antibody, TGF beta receptor type 2 antibody, TGF beta receptor type II antibody, TGF beta receptor type IIB antibody, TGF beta type II receptor antibody, TGF-beta receptor type II antibody, TGF-beta receptor type-2 antibody, TGF-beta type II receptor antibody, TGF-beta-R2 antibody, TGFB R2 antibody, TGFbeta - RII antibody, TGFbeta RII antibody, Tgfbr2 antibody, TGFR-2 antibody, TGFR2_HUMAN antibody, Transforming growth factor beta receptor II antibody, Transforming growth factor beta receptor type II antibody, Transforming growth factor beta receptor type IIC antibody, Transforming growth factor, beta receptor II (70/80 kDa) antibody, transforming growth factor, beta receptor II alpha antibody, transforming growth factor, beta receptor II beta antibody, transforming growth factor, beta receptor II delta antibody, transforming growth factor, beta receptor II epsilon antibody, transforming growth factor, beta receptor II gamma antibody, Transforming growth factor-beta receptor type II antibody

UniProt: P37173